Skip to search boxSkip to navigationSkip to main content

ADP-ribosylation factors modulate the cell surface transport of G protein-coupled receptors

  • Chunmin Dong
    ,
  • Xiaoping Zhang
    ,
  • Fuguo Zhou
    ,
  • Huijuan Dou
    ,
  • Matthew T. Duvernay
    ,
  • Ping Zhang
*Corresponding author for this work
  • Louisiana State University Health Sciences Center
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

ADP-ribosylation factors (ARFs) regulate vesicular traffic through recruiting coat proteins. However, their functions in the anterograde transport of nascent G protein-coupled receptors (GPCRs) from the endoplasmic reticulum to the plasma membrane remain poorly explored. Here we show that treatment with brefeldin A, an inhibitor of guanine nucleotide exchange on ARFs, markedly attenuated the cell surface numbers of α2B-adrenergic receptor (AR), β2-AR, angiotensin II type 1 receptor, and chemokine (CXC motif) receptor 4. Functional inhibition of individual ARF GTPases by transient expression of the GDP-bound, GTP-bound, and guanine nucleotide-deficient mutants showed that the five human ARFs differentially modulated receptor cell surface expression and that the ARF1 mutants produced the most profound inhibitory effect. Furthermore, expression of the ARF1 GTPase-activating protein (GAP) ARFGAP1 significantly blocked receptor transport. Interestingly, the GDP- and GTP-bound ARF1 mutants arrested the receptors in distinct intracellular compartments. Consistent with the reduced receptor cell surface expression, extracellular signal-regulated kinase 1 and 2 activation by receptor agonists was significantly attenuated by the GDP-bound mutant ARF1T31N. Moreover, coimmunoprecipitation showed that α2B-AR associated with ARF1 and glutathione transferase pull-down assay indicated that the α2B-AR C terminus directly interacted with ARF1. These data show that ARF1 GTPase is involved in the regulation of cell surface expression of GPCRs at multiple transport steps.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 174-183 (10 pages)

Journal (Volume, Issue Number)

Journal of Pharmacology and Experimental Therapeutics (Volume 333, Issue 1)

Publication milestones

  • Published - 04/2010

Publication status

Published - 04/2010

ISSN

0022-3565

Publication IDs

  • Scopus: 77949734021
  • PubMed: 20093398

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
1.14
SciVal
Author count
7
SciVal
citations
30
SciVal
Paper percentile
83
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
39
Captures
15

Funding Details

FunderFunding number
NIGMS
R01GM076167